Equillium Inc (EQ) concluded trading on Thursday at a closing price of $0.94, with 39.16 million shares of worth about $36.81 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 29.39% during that period and on February 06, 2025 the price saw a gain of about 33.03%. Currently the company’s common shares owned by public are about 35.42M shares, out of which, 17.42M shares are available for trading.
Stock saw a price change of 43.09% in past 5 days and over the past one month there was a price change of 23.18%. Year-to-date (YTD), EQ shares are showing a performance of 26.22% which increased to 18.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.49 but also hit the highest price of $3.25 during that period. The average intraday trading volume for Equillium Inc shares is 137.22K. The stock is currently trading 37.09% above its 20-day simple moving average (SMA20), while that difference is up 35.27% for SMA50 and it goes to 2.70% higher than SMA200.
Equillium Inc (NASDAQ: EQ) currently have 35.42M outstanding shares and institutions hold larger chunk of about 5.32% of that.
The stock has a current market capitalization of $33.46M and its 3Y-monthly beta is at 1.91. It has posted earnings per share of -$0.13 in the same period. It has Quick Ratio of 3.04 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EQ, volatility over the week remained 14.57% while standing at 13.01% over the month.
Stock’s fiscal year EPS is expected to rise by 1.32% while it is estimated to decrease by -129.33% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on October 29, 2021 offering a Buy rating for the stock and assigned a target price of $12 to it. Coverage by Cantor Fitzgerald stated Equillium Inc (EQ) stock as an Overweight in their note to investors on September 15, 2021, suggesting a price target of $14 for the stock. On July 14, 2020, H.C. Wainwright Reiterated their recommendations, while on July 10, 2020, Stifel Resumed their ratings for the stock with a price target of $10. Stock get an Outperform rating from SVB Leerink on February 22, 2019.
